{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:03:29Z","timestamp":1785769409817,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Research and Development Project of Ningxia Hui Autonomous Region","award":["2023BEG03046"],"award-info":[{"award-number":["2023BEG03046"]}]},{"name":"the Natural Science Foundation of Ningxia Hui Autonomous Region","award":["2022AAC03542"],"award-info":[{"award-number":["2022AAC03542"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10658-3","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T18:41:08Z","timestamp":1740768068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular epidemiology of Escherichia coli in bloodstream infections from a general hospital in Ningxia, China, 2022\u20132023"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinxin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"10658_CR1","doi-asserted-by":"crossref","unstructured":"MARTINEZ R M, WOLK DM. Bloodstream Infections [J] Microbiol Spectr, 2016, 4(4).","DOI":"10.1128\/microbiolspec.DMIH2-0031-2016"},{"issue":"4","key":"10658_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/CMR.00002-14","volume":"27","author":"DL LAUPLAND K B, CHURCH","year":"2014","unstructured":"LAUPLAND K B, CHURCH DL. Population-based epidemiology and microbiology of community-onset bloodstream infections [J]. Clin Microbiol Rev. 2014;27(4):647\u201364.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10658_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1747493016676285","volume":"12","author":"T THRIFT A G, THAYABARANATHAN","year":"2017","unstructured":"THRIFT A G, THAYABARANATHAN T, HOWARD G, et al. Global stroke statistics [J]. Int J Stroke: Official J Int Stroke Soc. 2017;12(1):13\u201332.","journal-title":"Int J Stroke: Official J Int Stroke Soc"},{"issue":"2","key":"10658_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/rth2.12101","volume":"2","author":"SC SCHERES L J J, LIJFERING W M, CANNE","year":"2018","unstructured":"SCHERES L J J, LIJFERING W M, CANNEGIETER SC. Current and future burden of venous thrombosis: not simply predictable [J]. Res Pract Thromb Haemostasis. 2018;2(2):199\u2013208.","journal-title":"Res Pract Thromb Haemostasis"},{"issue":"10120","key":"10658_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N CONRAD","year":"2018","unstructured":"CONRAD N, JUDGE A, TRAN J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals [J]. Lancet (London England). 2018;391(10120):572\u201380.","journal-title":"Lancet (London England)"},{"issue":"3","key":"10658_CR6","doi-asserted-by":"publisher","first-page":"e91713","DOI":"10.1371\/journal.pone.0091713","volume":"9","author":"DJ ANDERSON","year":"2014","unstructured":"ANDERSON DJ, MOEHRING R W, SLOANE R, et al. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study [J]. PLoS ONE. 2014;9(3):e91713.","journal-title":"PLoS ONE"},{"issue":"2","key":"10658_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1099\/jmm.0.000904","volume":"68","author":"X CHEN","year":"2019","unstructured":"CHEN X, ZOU Q, ZHANG W, et al. Clinical features and microbiological characteristics of hospital- and community-onset Escherichia coli bloodstream infection [J]. J Med Microbiol. 2019;68(2):178\u201387.","journal-title":"J Med Microbiol"},{"key":"10658_CR8","doi-asserted-by":"crossref","unstructured":"DAGA A P, KOGA V L, SONCINI J G M et al. Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics [J]. Frontiers in cellular and infection microbiology, 2019, 9(191.","DOI":"10.3389\/fcimb.2019.00191"},{"key":"10658_CR9","doi-asserted-by":"crossref","unstructured":"BASSETTI M, PECORI D, SIBANI M et al. Epidemiology and treatment of MDR Enterobacteriaceae [J]. 2015, 7(291\u2013316.","DOI":"10.1007\/s40506-015-0065-1"},{"key":"10658_CR10","doi-asserted-by":"crossref","unstructured":"CANT\u00f3N R, GONZ\u00e1LEZ-ALBA JM, GAL\u00e1N JC. CTX-M Enzymes: Origin and Diffusion [J]. Frontiers in microbiology, 2012, 3(110.","DOI":"10.3389\/fmicb.2012.00110"},{"key":"10658_CR11","doi-asserted-by":"crossref","unstructured":"VAN HOEK A H, MEVIUS D, GUERRA B et al. Acquired antibiotic resistance genes: an overview [J]. Frontiers in microbiology, 2011, 2(203.","DOI":"10.3389\/fmicb.2011.00203"},{"key":"10658_CR12","doi-asserted-by":"crossref","unstructured":"PHAM TD, ZIORA Z M, BLASKOVICH M A J. M. Quinolone antibiotics [J]. 2019, 10(10): 1719-39.","DOI":"10.1039\/C9MD00120D"},{"key":"10658_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2018.05.001","volume":"280","author":"D KUANG","year":"2018","unstructured":"KUANG D, ZHANG J, XU X, et al. Emerging high-level ciprofloxacin resistance and molecular basis of resistance in Salmonella enterica from humans, food and animals [J]. Int J Food Microbiol. 2018;280:1\u20139.","journal-title":"Int J Food Microbiol"},{"issue":"5","key":"10658_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijantimicag.2005.02.006","volume":"25","author":"HOPKINS K L","year":"2005","unstructured":"HOPKINS K L, DAVIES R H, THRELFALL E J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments [J]. Int J Antimicrob Agents. 2005;25(5):358\u201373.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10658_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1128\/AAC.34.6.1271","volume":"34","author":"H YOSHIDA","year":"1990","unstructured":"YOSHIDA H, BOGAKI M, NAKAMURA M, et al. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli [J]. Antimicrob Agents Chemother. 1990;34(6):1271\u20132.","journal-title":"Antimicrob Agents Chemother"},{"key":"10658_CR16","doi-asserted-by":"crossref","unstructured":"MITRA S, MUKHERJEE S, NAHA S et al. Evaluation of co-transfer of plasmid-mediated fluoroquinolone resistance genes and bla(NDM) gene in Enterobacteriaceae causing neonatal septicaemia [J]. Antimicrobial resistance and infection control, 2019, 8(46.","DOI":"10.1186\/s13756-019-0477-7"},{"issue":"1","key":"10658_CR17","doi-asserted-by":"publisher","first-page":"e0190729","DOI":"10.1371\/journal.pone.0190729","volume":"13","author":"M VARUGHESE L R, RAJPOOT","year":"2018","unstructured":"VARUGHESE L R, RAJPOOT M. Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC [J]. PLoS ONE. 2018;13(1):e0190729.","journal-title":"PLoS ONE"},{"issue":"8","key":"10658_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"REDGRAVE L S","year":"2014","unstructured":"REDGRAVE L S, SUTTON S B, WEBBER M A, et al. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success [J]. Trends Microbiol. 2014;22(8):438\u201345.","journal-title":"Trends Microbiol"},{"key":"10658_CR19","doi-asserted-by":"crossref","unstructured":"RUIZ J. Transferable mechanisms of Quinolone Resistance from 1998 onward [J]. Clin Microbiol Rev, 2019, 32(4).","DOI":"10.1128\/CMR.00007-19"},{"key":"10658_CR20","doi-asserted-by":"crossref","unstructured":"XIAO S, TANG C, ZENG Q et al. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli From Bloodstream Infection in Shanghai, China, 2016\u20132019 [J]. Frontiers in medicine, 2021, 8(803837.","DOI":"10.3389\/fmed.2021.803837"},{"key":"10658_CR21","doi-asserted-by":"crossref","unstructured":"XIANG G, LAN K, CAI Y et al. Clinical Molecular and Genomic Epidemiology of Morganella morganii in China [J]. Frontiers in microbiology, 2021, 12(744291.","DOI":"10.3389\/fmicb.2021.744291"},{"issue":"10","key":"10658_CR22","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","volume":"40","author":"EVERETTMJ JIN Y F","year":"1996","unstructured":"JIN Y F EVERETTMJ. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J]. Antimicrob Agents Chemother. 1996;40(10):2380\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"10658_CR23","unstructured":"CLSI I J C W LEWISS, NJ. USA. M100 Performance standards for antimicrobial susceptibility testing [J]. 2022."},{"issue":"2","key":"10658_CR24","doi-asserted-by":"publisher","first-page":"e067840","DOI":"10.1136\/bmjopen-2022-067840","volume":"13","author":"PW BLAIR","year":"2023","unstructured":"BLAIR PW, MEHTA R, OPPONG C K, et al. Screening tools for predicting mortality of adults with suspected sepsis: an international sepsis cohort validation study [J]. BMJ open. 2023;13(2):e067840.","journal-title":"BMJ open"},{"issue":"1","key":"10658_CR25","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.1038\/s41598-022-12569-8","volume":"12","author":"MOHUS R M","year":"2022","unstructured":"MOHUS R M, GUSTAD L T, FURBERG A S, et al. Explaining sex differences in risk of bloodstream infections using mediation analysis in the population-based HUNT study in Norway [J]. Sci Rep. 2022;12(1):8436.","journal-title":"Sci Rep"},{"key":"10658_CR26","doi-asserted-by":"crossref","unstructured":"NAAS T, POIREL L. NORDMANN P. Minor extended-spectrum beta-lactamases [J]. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious diseases, 2008, 14 Suppl 1(42\u201352.","DOI":"10.1111\/j.1469-0691.2007.01861.x"},{"issue":"6","key":"10658_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/MCC.0b013e32834c9d87","volume":"17","author":"VAN DUIJN P J","year":"2011","unstructured":"VAN DUIJN P J, DAUTZENBERG M J, OOSTDIJK E A. Recent trends in antibiotic resistance in European ICUs [J]. Curr Opin Crit Care. 2011;17(6):658\u201365.","journal-title":"Curr Opin Crit Care"},{"key":"10658_CR28","doi-asserted-by":"crossref","unstructured":"GUENTHER S, EWERS C. WIELER L H. Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution? [J]. Frontiers in microbiology, 2011, 2(246.","DOI":"10.3389\/fmicb.2011.00246"},{"issue":"10","key":"10658_CR29","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1128\/AAC.01127-16","volume":"60","author":"Y ZHANG","year":"2016","unstructured":"ZHANG Y, ZHAO C, WANG Q, et al. High prevalence of Hypervirulent Klebsiella pneumoniae infection in China: Geographic distribution, clinical characteristics, and Antimicrobial Resistance [J]. Antimicrob Agents Chemother. 2016;60(10):6115\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10658_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jinf.2006.01.014","volume":"54","author":"Y YU","year":"2007","unstructured":"YU Y, JI S, CHEN Y, et al. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China [J]. J Infect. 2007;54(1):53\u20137.","journal-title":"J Infect"},{"issue":"7","key":"10658_CR31","doi-asserted-by":"publisher","first-page":"e100707","DOI":"10.1371\/journal.pone.0100707","volume":"9","author":"S XIA","year":"2014","unstructured":"XIA S, FAN X, HUANG Z, et al. Dominance of CTX-M-type extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China [J]. PLoS ONE. 2014;9(7):e100707.","journal-title":"PLoS ONE"},{"issue":"4","key":"10658_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","volume":"22","author":"J STRAHILEVITZ","year":"2009","unstructured":"STRAHILEVITZ J, JACOBY G A, HOOPER D C, et al. Plasmid-mediated quinolone resistance: a multifaceted threat [J]. Clin Microbiol Rev. 2009;22(4):664\u201389.","journal-title":"Clin Microbiol Rev"},{"issue":"37","key":"10658_CR33","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1021\/bi800664x","volume":"47","author":"SS VETTING M W, PARK C H, HEGDE","year":"2008","unstructured":"VETTING M W, PARK C H, HEGDE SS, et al. Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6\u2019)-Ib and its bifunctional, fluoroquinolone-active AAC(6\u2019)-Ib-cr variant [J]. Biochemistry. 2008;47(37):9825\u201335.","journal-title":"Biochemistry"},{"issue":"2","key":"10658_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijantimicag.2015.03.008","volume":"46","author":"M FERN\u00e1NDEZ-MART\u00edNEZ","year":"2015","unstructured":"FERN\u00e1NDEZ-MART\u00edNEZ M, MIR\u00f3 E, ORTEGA A, et al. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin\/clavulanic acid isolated in Spain [J]. Int J Antimicrob Agents. 2015;46(2):157\u201363.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10658_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jac\/dks365","volume":"68","author":"S PALTANSING","year":"2013","unstructured":"PALTANSING S, KRAAKMAN M E, RAS JM, et al. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE [J]. J Antimicrob Chemother. 2013;68(1):40\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10658_CR36","first-page":"183","volume":"33","author":"TK DAS B, SHAMSUZZAMAN S M, DAS","year":"2024","unstructured":"DAS B, SHAMSUZZAMAN S M, DAS TK. Detection of Quinolone resistance qnr genes and its association with extended spectrum \u03b2-lactamase and AmpC \u03b2-lactamase genes in qnr positive Enterobacteriaceae in Bangladesh [J]. Mymensingh Med Journal: MMJ. 2024;33(1):183\u201391.","journal-title":"Mymensingh Med Journal: MMJ"},{"key":"10658_CR37","doi-asserted-by":"crossref","unstructured":"DALHOFF A. Global fluoroquinolone resistance epidemiology and implictions for clinical use [J]. Interdisciplinary perspectives on infectious diseases; 2012. 2012(976273.","DOI":"10.1155\/2012\/976273"},{"issue":"4","key":"10658_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrmicro1128","volume":"3","author":"SJ COULTHURST","year":"2005","unstructured":"COULTHURST SJ, BARNARD A M, SALMOND GP. Regulation and biosynthesis of carbapenem antibiotics in bacteria [J]. Nat Rev Microbiol. 2005;3(4):295\u2013306.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10658_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","volume":"11","author":"G CORNAGLIA","year":"2011","unstructured":"CORNAGLIA G, GIAMARELLOU H, ROSSOLINI GM. Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams? [J]. Lancet Infect Dis. 2011;11(5):381\u201393.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10658_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","volume":"78","author":"K ZHANEL G G, LAWRENCE C","year":"2018","unstructured":"ZHANEL G G, LAWRENCE C K, ADAM H, et al. Imipenem-Relebactam and Meropenem-Vaborbactam: two Novel Carbapenem-\u03b2-Lactamase inhibitor combinations [J]. Drugs. 2018;78(1):65\u201398.","journal-title":"Drugs"},{"key":"10658_CR41","doi-asserted-by":"crossref","unstructured":"FERNANDES R, AMADOR P, PRUD\u00eaNCIO CJR et al. \u03b2-Lactams: chemical structure, mode of action and mechanisms of resistance [J]. 2013, 24(1): 7\u201317.","DOI":"10.1097\/MRM.0b013e3283587727"},{"issue":"8","key":"10658_CR42","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1128\/AAC.00099-14","volume":"58","author":"R ALMAGHRABI","year":"2014","unstructured":"ALMAGHRABI R, CLANCY C J, DOI Y, et al. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents [J]. Antimicrob Agents Chemother. 2014;58(8):4443\u201351.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10658_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molmed.2012.03.003","volume":"18","author":"P NORDMANN","year":"2012","unstructured":"NORDMANN P, DORTET L. Carbapenem resistance in Enterobacteriaceae: here is the storm! [J]. Trends Mol Med. 2012;18(5):263\u201372.","journal-title":"Trends Mol Med"},{"key":"10658_CR44","doi-asserted-by":"crossref","unstructured":"QUEENAN A M BUSHK. Carbapenemases: the versatile beta-lactamases [J]. Clin Microbiol Rev, 2007, 20(3): 440\u2013\u200958, table of contents.","DOI":"10.1128\/CMR.00001-07"},{"key":"10658_CR45","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.2147\/IDR.S226416","volume":"12","author":"M DI TELLA D, TAMBURRO","year":"2019","unstructured":"DI TELLA D, TAMBURRO M, GUERRIZIO G, et al. Molecular Epidemiological insights into Colistin-resistant and carbapenemases-producing clinical Klebsiella pneumoniae isolates [J]. Infect drug Resist. 2019;12:3783\u201395.","journal-title":"Infect drug Resist"},{"issue":"7","key":"10658_CR46","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","volume":"41","author":"S YAGHOUBI","year":"2022","unstructured":"YAGHOUBI S, ZEKIY A O KRUTOVAM, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review [J]. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 2022;41(7):1003\u201322.","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"issue":"5","key":"10658_CR47","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm900999h","volume":"53","author":"T VELKOV","year":"2010","unstructured":"VELKOV T, THOMPSON P E, NATION R L, et al. Structure\u2013activity relationships of polymyxin antibiotics [J]. J Med Chem. 2010;53(5):1898\u2013916.","journal-title":"J Med Chem"},{"issue":"1","key":"10658_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13073-021-00947-2","volume":"13","author":"S LIPWORTH","year":"2021","unstructured":"LIPWORTH S, VIHTA K D, CHAU K, et al. Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK [J]. Genome Med. 2021;13(1):144.","journal-title":"Genome Med"},{"issue":"12","key":"10658_CR49","doi-asserted-by":"publisher","first-page":"e0244358","DOI":"10.1371\/journal.pone.0244358","volume":"15","author":"F PARAMITA R I, NELWAN E J, FADILAH","year":"2020","unstructured":"PARAMITA R I, NELWAN E J, FADILAH F, et al. Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing [J]. PLoS ONE. 2020;15(12):e0244358.","journal-title":"PLoS ONE"},{"key":"10658_CR50","doi-asserted-by":"crossref","unstructured":"NAMAEI M H, YOUSEFI M, ZIAEE M et al. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b\/ST131 from Iran [J]. Microbial drug resistance (Larchmont, NY), 2017, 23(7): 879\u201384.","DOI":"10.1089\/mdr.2016.0272"},{"issue":"1","key":"10658_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12866-019-1493-8","volume":"19","author":"Z HOJABRI","year":"2019","unstructured":"HOJABRI Z, DARABI N, ARAB M, et al. Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. Coli ST131 and non-ST131 isolates from Iran [J]. BMC Microbiol. 2019;19(1):117.","journal-title":"BMC Microbiol"},{"issue":"10","key":"10658_CR52","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1128\/AAC.00641-13","volume":"57","author":"Y MATSUMURA","year":"2013","unstructured":"MATSUMURA Y, YAMAMOTO M, NAGAO M, et al. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups [J]. Antimicrob Agents Chemother. 2013;57(10):4736\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"10658_CR53","doi-asserted-by":"crossref","unstructured":"DE SOUZA DA-SILVA A P, DE SOUSA V S, DE ARA\u00faJO LONGO L G et al. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131 [J]. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, 85(104452.","DOI":"10.1016\/j.meegid.2020.104452"},{"issue":"2","key":"10658_CR54","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jinf.2009.11.004","volume":"60","author":"LEE M Y","year":"2010","unstructured":"LEE M Y, CHOI H J, CHOI J Y, et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea [J]. J Infect. 2010;60(2):146\u201353.","journal-title":"J Infect"},{"issue":"2","key":"10658_CR55","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cid\/ciy525","volume":"68","author":"TCHESNOKOVAVL RECHKINA","year":"2019","unstructured":"RECHKINA TCHESNOKOVAVL. Rapid and extensive expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, sequence type 1193 [J]. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2019;68(2):334\u20137.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"10658_CR56","doi-asserted-by":"crossref","unstructured":"WU J, LAN F, LU Y et al. Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant Escherichia coli [J]. Frontiers in microbiology, 2017, 8(2294.","DOI":"10.3389\/fmicb.2017.02294"}],"updated-by":[{"DOI":"10.1186\/s12879-025-10746-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10658-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T11:43:43Z","timestamp":1741607023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10658-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10658"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10658-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-025-10746-4","URL":"https:\/\/doi.org\/10.1186\/s12879-025-10746-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, this retrospective study was permitted by the ethics committee of the General Hospital of Ningxia Medical University, and the requirement to obtain informed written consent was waived. To protect patients\u2019 personal information and maintain the security of General Hospital of Ningxia Medical University\u2019s patient information, we are committed to fulfilling our obligation to keep patients\u2019 personal information confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}